Susan Hasty, Publisher
Table of Contents . . . May 11th, 2010
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Physician Business Week | Other Publications
Biotechnology Business - Arrowhead Announces the Appointment of Former FDA Commissioner and National Cancer Institute Director Dr. Andrew von Eschenbach to Its Board of Advisors
AstraZeneca - AstraZeneca Traveling Patient Health Exhibit Continues to Help Americans Understand and Manage Bipolar Depression
Heart Attack - CRESTOR Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Anemia - Changes Brewing in the Renal Anemia Market, According to Two Recent Publications from BioTrends
Merck & Co., Inc. - Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Regulatory Agencies - Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
Pediatric Research - The Children's Hospital of Philadelphia Joins Aetna Better Health Network
Medicare and Medicaid - Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Lung Cancer - Use and costs of diagnostic imaging increasing for patients with cancer
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.